Rosuvastatin Recruiting Phase 2 Trials for Osteoporosis and Cardio-Metabolic Syndrome Following Spinal Cord Injury / Spinal Cord Injuries (SCI) / Metabolic Syndromes / Osteoporosis Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03113994Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk